Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Gongdong Medical Technology CoSHSE:605369 +1.45%72 Return-on-Tangible-Equity is 9.23% as of Mar. 2026, which is 63% below its 10-year median of 25.15. GuruFocus rates SHSE:605369 with a GF Score™ of 72/100 and a GF Value™ of ¥26.70 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Zhejiang Gongdong Medical Technology Co ranks better than 50.33% on this metric.
SHSE:605369'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.79 Med: 25.15 Max: 41.36
Current: 4.09
During the past 10 years, Zhejiang Gongdong Medical Technology Co's highest Return-on-Tangible-Equity was 41.36%. The lowest was 3.79%. And the median was 25.15%.
SHSE:605369's Return-on-Tangible-Equity is ranked better than 50.33% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.02
vs SHSE:605369: 4.09
Zhejiang Gongdong Medical Technology Co (SHSE:605369) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Zhejiang Gongdong Medical Technology Co Return-on-Tangible-Equity Related Terms
Zhejiang Gongdong Medical Technology Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Gongdong Medical Technology Co Return-on-Tangible-Equity Chart
Zhejiang Gongdong Medical Technology Co Annual Data
SHSE:605369 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Gongdong Medical Technology Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.23% mean?
Zhejiang Gongdong Medical Technology Co (SHSE:605369) has a Return-on-Tangible-Equity of 9.23% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Zhejiang Gongdong Medical Technology Co and its competitors. This is 63% below median its historical median of 25.15. Over the past decade, Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity has ranged from 3.79 to 41.36. According to the industry distribution chart, Zhejiang Gongdong Medical Technology Co ranks #377 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 49.7%.
Is Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity too high?
Zhejiang Gongdong Medical Technology Co's current Return-on-Tangible-Equity of 9.23% is 63% below median its 10-year median of 25.15. Over the past 10 years, this metric has ranged from a low of 3.79 to a high of 41.36. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.02. Zhejiang Gongdong Medical Technology Co's value of 9.23% is 129.6% above this industry median. Based on the distribution chart, Zhejiang Gongdong Medical Technology Co ranks #377 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zhejiang Gongdong Medical Technology Co has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Gongdong Medical Technology Co's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zhejiang Gongdong Medical Technology Co ranks #377 out of 759 companies for Return-on-Tangible-Equity. This puts Zhejiang Gongdong Medical Technology Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.02. Zhejiang Gongdong Medical Technology Co's value of 9.23% is 129.6% above this benchmark. Historically, Zhejiang Gongdong Medical Technology Co's own Return-on-Tangible-Equity has ranged from 3.79 to 41.36 over the past decade. While the company's 10-year median is 25.15 vs. the industry median of 4.02, Zhejiang Gongdong Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.02, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Gongdong Medical Technology Co's current Return-on-Tangible-Equity of 9.23% is 129.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Zhejiang Gongdong Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Gongdong Medical Technology Co's current Return-on-Tangible-Equity is 9.23%, which is 63% below median its own 10-year median of 25.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Gongdong Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Gongdong Medical Technology Co (SHSE:605369) is currently considered Possible Value Trap. The stock's GF Value™ is ¥26.70, compared to a current price of ¥16.13 — trading 39.6% below its estimated fair value. The current Return-on-Tangible-Equity is 9.23%, which is 63% below median its 10-year median of 25.15 and 129.6% above the Medical Devices & Instruments industry median of 4.02. Zhejiang Gongdong Medical Technology Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Zhejiang Gongdong Medical Technology Co (SHSE:605369), the current Return-on-Tangible-Equity is 9.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Gongdong Medical Technology Co (SHSE:605369) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Gongdong Medical Technology Co stock appears to be undervalued.
The current stock price of ¥16.13 is trading 39.6% below its estimated GF Value™ of ¥26.70.
GuruFocus considers Zhejiang Gongdong Medical Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:605369:
Return-on-Tangible-Equity: 9.23% (63% below median its 10-year median of 25.15)
GF Value™: ¥26.70 vs. price of ¥16.13 (39.6% below fair value)
Industry Position: 129.6% above the Medical Devices & Instruments median (#377 of 759)
No single metric tells the full story. See the SHSE:605369 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Gongdong Medical Technology Co Ltd is engaged in production and sales of disposable medical devices, and medical testing supplies. The company's products include Vacuum Blood collection system; Specimen Collection system; Petri Dish Family; Centrifugation Tube; Vaginal Speculum; Surgical Supplies; Pipette tip; Transfer Pipette; Test Tube; Test Tube Racks; and Colorimetric Cup.
72GF Score
Get the complete analysis for SHSE:605369
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605369 has been successfully added to your 
